Case Fatalities in Hospitalised COVID-19 Patients in the UK
NCT04527458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70000
Last updated 2020-08-26
Summary
This study will investigate how the case fatality in hospitalised patients with COVID-19 has changed throughout the pandemic. It will also explore possible mechanisms that could be driving these changes. This analysis will enhance our understanding of the virus, which will be important for researchers and clinicians to respond appropriately.
Conditions
- Covid19
Interventions
- OTHER
-
Patient Characteristics
Characteristics of the patients
- OTHER
-
COVID-19 treatments
Specific treatments used on COVID-19 patients
- OTHER
-
Differences in triage
Triage criteria for treating COVID-19 patients
- OTHER
-
Surge capacity
Capacity of hospitals
Sponsors & Collaborators
-
International Severe Acute Respiratory and Emerging Infection Consortium
collaborator OTHER -
BREATHE Health Data Research Hub
collaborator UNKNOWN -
University of Edinburgh
lead OTHER
Principal Investigators
-
Annemarie B Docherty · Usher Institute, University of Edinburgh
-
Ewen M Harrison · Usher Institute, University of Edinburgh
-
Rachel H Mulholland · Usher Institute, University of Edinburgh
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-24
- Primary Completion
- 2020-08-02
- Completion
- 2020-08-02
Countries
- United Kingdom
Study Locations
More Related Trials
-
I VACCIN Hospitalization of COVID-19 Patients
NCT05244343 ·Status: COMPLETED
-
Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)
NCT05244330 ·Status: COMPLETED
-
Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19)
NCT04332094 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.
NCT06057025 ·Status: UNKNOWN ·Phase: PHASE3
-
CORE Study COVID-19
NCT04531202 ·Status: UNKNOWN
-
SARS-CoV-2 Infection in COVID-19 Vaccinated Patients
NCT05060939 ·Status: COMPLETED ·Phase: NA
-
Microbial Infection and AMR in Hospitalized Patients With Covid 19
NCT04479982 ·Status: UNKNOWN
-
TOcilizumab and Covid-19 : Risk of Severe INfection
NCT05017441 ·Status: UNKNOWN
-
COVID-19 Vaccination AZV 2021-2023
NCT05589233 ·Status: COMPLETED
-
Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)
NCT05716425 ·Status: COMPLETED ·Phase: PHASE3
-
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
NCT04479488 ·Status: COMPLETED
-
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
NCT05822193 ·Status: RECRUITING
-
Evaluation of the Efficacy and Safety of Nano-S1
NCT05822180 ·Status: COMPLETED ·Phase: PHASE3
-
An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS
NCT00754273 ·Status: COMPLETED
-
Immune Response and Risk of Serious Infection to SARS-Cov2
NCT04410432 ·Status: COMPLETED
-
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
NCT04345315 ·Status: UNKNOWN
-
Surveillance of AMR in DRC
NCT06821282 ·Status: RECRUITING
-
Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites
NCT05769803 ·Status: UNKNOWN ·Phase: NA
-
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
NCT05020145 ·Status: COMPLETED
-
Nasal Swab Study to Explore the Nasal Microbia
NCT02535442 ·Status: COMPLETED
-
EMPOWER - BAME vs COVID
NCT04399733 ·Status: WITHDRAWN
-
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.
NCT04402827 ·Status: COMPLETED
-
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.
NCT04885452 ·Status: COMPLETED
-
Correlation Between Cycle Threshold (Ct) Values in COVID-19, Health Status and Laboratory Biomarkers in the Population of Medellin- Colombia Evaluated in a Specialized Laboratory.
NCT05067920 ·Status: UNKNOWN
-
Invasive Markers of Staphylococcus Epidermidis
NCT03374371 ·Status: COMPLETED